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Abstract
The capacity to adequately respond to (physiological) perturbations is a fundamental aspect of physiology, and may affect 
health and thereby Darwinian fitness. However, little is known of the degree of individual variation in this capacity in non-
model organisms. The glucose tolerance test evaluates the individual’s ability to regulate circulating glucose levels, and is 
a widely used tool in medicine and biomedical research, because glucose regulation is thought to play a role in the ageing 
process, among other reasons. Here, we developed an application of the intraperitoneal glucose tolerance test (IP-GTT) to 
be used in small birds, to test whether individuals can be characterized by their regulation of glucose levels and the effect 
of successive handling on such regulation. Since the IP-injection (intraperitoneal glucose injection), repeated handling and 
blood sampling may trigger a stress response, which involves a rise in glucose levels, we also evaluated the effects of han-
dling protocols on glucose response. Blood glucose levels decreased immediately following an IP-injection, either vehicle 
or glucose loaded, and increased with successive blood sampling. Blood glucose levels peaked, on average, at 20 min post-
injection (PI) and had not yet returned back to initial levels at 120 min PI. Glucose measurements taken during the IP-GTT 
were integrated to estimate magnitude of changes in glucose levels over time using the incremental area under the curve 
(AUC) up to 40 min PI. Glucose levels integrated in the AUC were significantly repeatable within individuals over months 
(r = 50%; 95% CI 30–79%), showing that the ability to regulate glucose differs consistently between individuals.
Keywords Glucose tolerance test · Glucose regulation · Repeatability · Taenopygia guttata
Introduction
Glucose is an important source of energy for several tis-
sues. In vertebrates, its regulation involves the coordinated 
action of multiple organs and has an impact on protein and 
lipid metabolism (Hazelwood 2000; Bernard et al. 2003; 
Braun and Sweazea 2008). Thereby, glucose regulation is 
a life sustaining process and variations in this process may 
affect individual’s performance (Hazelwood 2000; Bernard 
et al. 2003; Braun and Sweazea 2008; Scanes 2015; but see 
Ramenofsky 1990). An effective response of glucose regu-
lation is recognized as a hallmark of health in humans and 
laboratory models, and its impairment has been linked to 
mechanisms associated with the ageing process (Gardner 
et al. 2005; Semba et al. 2010; Picard et al. 2014; Regan 
et al. 2020). Although glucose regulation is thought to be 
plastic (i.e. a single genotype may produce multiple pheno-
types in response to environmental changes), the few studies 
available with non-model organisms suggest this trait to still 
be repeatable within individuals (Pratt et al. 2005; Bröjer 
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et al. 2013). However, further studies are required to bet-
ter understand to what extent glucose regulation capacity is 
consistent throughout an individual’s life, and thereby can 
systematically affect individual’s physiological performance, 
and be considered an individual trait that is potentially a 
subject of selection.
The glucose tolerance test (GTT) is a widely used tool 
to investigate the capacity to regulate glucose in humans 
and laboratory animal models (Andrikopoulos et al. 2008; 
Babbar et al. 2018). Using repeated blood sampling, the 
GTT measures how fast an orally or injection administrated 
glucose dose is cleared from the blood stream, bringing glu-
cose concentration back to pre-administration levels. Glu-
cose regulation has been little studied in non-model organ-
isms, and studies available on birds are mostly restricted 
to poultry (Heald et al. 1965; Boswell et al. 1997; Brzęk 
et al. 2010; Datar and Bhonde 2011; Sumners et al. 2014). 
Birds are interesting in this respect, because avian plasma 
glucose concentrations are considerably higher when com-
pared to mammals of similar body mass (Braun and Sweazea 
2008). These high levels are apparently maintained without 
compromising avian organismal functioning, as suggested 
by the longer lifespans of birds compared to mammals of 
similar body mass (Holmes et al. 2001; Scanes and Braun 
2013). However, when comparing individuals, high baseline 
glucose levels are associated with shorter lifespans in zebra 
finches Taenopygia guttata (Montoya et al. 2018), collared 
flycatchers Ficedula albicollis (Récapet et al. 2016, glycated 
hemoglobin), and blue tit nestlings Cyanistes caeruleus 
(Kaliński et al. 2014); and with growing up in poor-quality 
habitats in blue tit nestlings (Kaliński et al. 2014). Therefore, 
studying the capacity to regulate glucose may be a useful 
tool to estimate health state, monitor the consequences of 
habitat degradation on free living birds, and help to gain 
insights on the ageing process.
We applied an intra-peritoneal glucose tolerance test (IP-
GTT) to evaluate the repeatability of the ability to regulate 
glucose levels in zebra finches, and the effects of succes-
sive handling on this ability. Earlier studies have shown 
that blood glucose levels increase as part of the acute stress 
response (Remage-Healey and Romero 2001; Jimeno et al. 
2018a). Hence, considering that IP-GTT involves repeated 
handling (i.e. successive blood sampling) that may trigger 
a stress response, we first evaluated the effect of handling 
on blood glucose levels by varying the number and timing 
of blood samples, and comparing effects of injections with 
and without a glucose load. Second, we estimated glucose 
levels at different time intervals after the intra-peritoneal 
injection loaded with different doses of glucose. A proto-
col that applies the IP-GTT to small birds was not available 
prior to our study, and hence we developed a protocol to suit 
small birds on the basis of protocol-directed experiments. 
Performance in a GTT can be characterized by integrating 
several glucose measurements at successive time intervals 
(i.e. glucose curve), an strategy to do this is calculating the 
area under the glucose curve (hereafter AUC) using the trap-
ezoidal method, we implemented this common approach 
used when testing glucose tolerance (Fig S1; Le Floch et al. 
1990; Andrikopoulos et al. 2008).
Methods
Housing
Individuals included in the study were randomly selected 
from the zebra finch colony of the University of Gronin-
gen, the Netherlands (53° 13′ 0″ N/6° 33′ 0″ E). Adult birds 
were housed in single sex outdoor aviaries (L × H × W: 
310 × 210 × 150 cm) and individually identified with a num-
bered metal ring. Birds had ad libitum access to tropical 
seed mixture, cuttlebone, egg food, water and sand (Bogena, 
Hedel, The Netherlands). These housing conditions are simi-
lar to those in other facilities (e.g. Griffith et al. 2017).
Blood sampling
Data were collected between June 16th and September 4th 
2014. Birds were captured using handheld nets, and indi-
vidually placed in a box with a wire mesh top (L × W × H: 
40 × 40 × 15 cm) without access to food or water. Individu-
als were then maintained in low-light conditions for 30 min 
prior to sampling (following Montoya et al. 2018). Blood (40 
µL per sample) was taken from the brachial vein by punctur-
ing the vein each time, starting from a distal position in the 
vein with respect to animal’s body, and alternating between 
wings among samples. Blood was collected in heparinized 
microcapillary tubes, and immediately after sampling, was 
added to a heparin (500 IU/mL)—EDTA (0.01%) solution 
(760 µL per sample), and stored on ice for up to 40 min. 
All samples were then frozen at − 20 °C for a maximum 
of 48 h before glucose measurement. We first performed a 
pilot test to evaluate whether glucose concentration in frozen 
plasma and frozen whole blood were correlated. The amount 
of blood taken per individual on a single day never exceeded 
160 µL. After blood sampling, individuals were left undis-
turbed in the waiting box for an hour, at a warm place (near 
an incandescent light bulb) with ad libitum access to food 
and water, before being returned to their aviary.
Protocol development
A schematic overview of protocol-directed experiments, 
including specific aim and sample size, is presented in 
Table 1 in chronological order. The aim of these sequential 
experiments was to determine the optimal conditions for 
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the IP-GTT in zebra finches, over which we calculated 
repeatability estimates. Administrating glucose through IP 
injection was chosen over an oral supplementation because 
in a pilot study using the oral version of the protocol, birds 
required longer to reach glucose peak values, making the 
whole protocol considerably longer (S. Moonen and S. 
Verhulst unpublished data). In experiment 1, we tested 
the effect of the IP-injection on initial glucose levels by 
sampling a subset of individuals immediately before or 
after an IP-injection that was loaded with either 20% glu-
cose or saline solution. This experiment was performed 
over six days and included 82 birds. In experiment 2, we 
evaluated if the glucose trajectory, i.e. the glucose levels 
in the three subsequent post-injection (PI) measurements, 
was affected by the timing of the first sample (i.e. before 
or after IP-injection) and the load of the IP-injection (0 
or 20% glucose); sampling sessions were performed over 
five days and 56 individuals were tested. In experiment 3, 
we assessed the effect of successive handling on glucose 
levels by dividing birds into two subsets: half of them had 
four blood samples of the GTT taken (T0, T10, T20 and 
T40 min PI), while the other half had only the first and 
the last sample of the GTT taken (T0 and T40 min PI). IP-
injection was loaded with either 0 or 20% glucose, and the 
44 birds included in the experiment were sampled within 
three days. In experiment 4, we selected the optimal glu-
cose concentration for the IP-injection, by comparing the 
effect of 0, 20 and 30% glucose doses on blood glucose 
levels of individuals successively handled during the GTT 
(i.e. four samples taken). Tests were performed within five 
days and included 50 individuals. In experiment 5, we 
explored the performance of individuals using the final 
IP-GTT protocol developed through experiments 1–4; 24 
individuals were tested. In experiment 6, we evaluated the 
effect of delaying the last sample of the GTT until T120 
min PI on blood glucose levels, with 22 birds included in 
the experiment. Individual birds were used only once in 
each of the six experiments described above.
Glucose or saline solution (control) were always admin-
istrated intra-peritoneally. There is no standard dose for the 
GTT in birds, and previous studies have used a range from 
1 to 80% glucose solution in oral and intravenous versions 
of the GTT (Muiruri et al. 1975; Ramachandran and Patel 
1989; Joseph et al. 1996; Totzke et al. 1998). We injected 
100 µL of a 20 or 30% d( +)-glucose monohydrate solu-
tion  (C6H12O6—saline solution, Merck KGaA, Darmstadt, 
Germany), kept on ice, on the midline abdomen (~ 0.25 cm 
to left side of the midline and ~ 0.5 cm above cloaca). This 
dosage closely corresponds to the optimal reported for mice 
during an IP-GTT, 2 gr/kg (Andrikopoulos et al. 2008). In 
all experiments, we used the sampling interval as reported 
by Brzęk et al. (2010), but blood sampling at T60, T120 and 
T180 min after injection was omitted due to limitations on 
the blood volume that can be taken from birds as small as 
zebra finches (however, see experiment 6).
Glucose measurements
The Hoffman’s ferricyanide method was used to determine 
glucose levels in whole blood (Hoffman 1937). Standard 
curve and samples were read in a Technicon autoanalyzer 
(Beckman Coulter LX20PRO). A standard glucose curve 
was included at the beginning and end of each assay session, 
and glucose values were estimated using the average values 
of the two curves. Blood samples were analyzed in duplicate, 
and statistical calculations were performed on the average 
of the two duplicates, of which the extrapolated repeatabil-
ity was 86% (calculated following Eq. 37 in Nakagawa and 
Schielzeth 2010).
We used area under the glucose curve (AUC) to quan-
tify the response to the glucose injection. We calculated the 
incremental AUC using the trapezoidal method (Tai 1994). 
The AUC was calculated from the glucose levels in four con-
secutive blood samples, just before glucose injection (T0-
G0), at 10 min (T10-G10), 20 min (T20-G20) and 40 min 
(T40-G40) after glucose injection as shown in Figure S1. 
When G3 was below G0, which was unusual (6/56 cases), 
we estimated the time point at which initial glucose level 
(G0) was reached using the interpolation of the equation of 
the line G20 and G40, and taking the resulting time point 
to calculate area c in Figure S1. In addition to the AUC 
as described above, we also calculated the AUC up to the 
moment that, on average, the peak glucose level was reached 
(T20 min PI), and we denoted this as the AUCpeak.
Statistical analyses
We analyzed the data with linear mixed models using the 
function lmer of the package lme4 in R version 3.3.1 (Bates 
et al. 2015, R core team 2017). P values were obtained using 
the package lmerTest (Kuznetsova et al. 2017) and post-
hoc tests were performed with the package emmeans (Lenth 
2019). Unless mentioned otherwise, blood glucose level was 
the dependent variable in all models.
The effect of the IP-injection on initial glucose level (G0) 
(experiment 1) was tested in a model including IP-injection 
time (before or after initial sampling), injection load (0 or 
20% glucose) and sex as fixed factors, and sampling time 
(hour of day) as a covariate. In this and subsequent analyses 
the inclusion of sex and sampling time in no case explained 
a significant part of the variance, and hence all results are 
reported without further reference to these variables.
The influence of IP-injection on glucose levels (experi-
ment 2) was evaluated in a model that included as response 
variable the glucose levels obtained in the four samples taken 
(G0, G10, G20, G40), and as fixed factors the IP-injection 
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time (before or after initial sampling), the injection load (0 
or 20% glucose), and the sample number (i.e. T0, T10, T20 
or T40). Interactions of injection timing with sample num-
ber and injection load were also tested. Bird identity was 
included as a random effect.
The impact of successive handling on glucose levels 
(experiment 3) was explored fitting a model including the 
injection load (0 or 20% glucose), the sample number (T0, 
T10, T20 or T40), and the number of samples taken (either 
two samples, at T0 and T40 min PI, or four samples at T0, 
T10, T20 and T40 min PI) as fixed factors, and testing the 
interactions of number of samples taken (two or four) with 
injection load and with sample number (T0, T10, T20 or 
T40); bird identity was maintained as a random effect.
The effect of the glucose concentration of the IP-injection 
on blood glucose levels during successive handling (experi-
ment 4) was evaluated including injection load (0, 20 or 30% 
glucose) and sample number (T0, T10, T20 or T40) as main 
effects, and the interaction between these two factors. Bird 
identity was included as a random effect.
The performance of the birds in the IP-GTT (i.e. under 
the conditions defined through experiments 1–4, experiment 
5) was evaluated by including blood glucose levels at initial 
(G0) and all PI samples as response variable (G10, G20 and 
G40), and sample number (T0, T10, T20 or T40) as fixed 
factor. Bird identity was included as a random effect. The 
effect of delaying the final blood sample up to T120 min PI 
(experiment 6) was analyzed as described for experiment 5. 
Finally, we fitted a model including AUC as response vari-
able, whether it was the first or second AUC measurement 
for a given bird, the time at which peak was attained and 
the glucose concentration at peak as fixed effects, and bird 
identity as a random effect. Repeatability was calculated by 




Glucose levels measured in plasma and whole blood fro-
zen samples were moderately correlated (r = 0.72, N = 8, 
P = 0.04; Fig S2). It is worth noting that this correlation 
underestimates the true association between glucose esti-
mates, because it was not corrected for measurement error. 
Correcting for measurement error on both axes following 
Muchinsky (1996), i.e. calculating the disattenuated correla-
tion coefficient, yields a disattenuated correlation of r = 0.99. 
Therefore, glucose concentrations were analyzed in frozen 
whole blood samples to minimize sample handling, and 
to avoid variation among samples related to the degree of 
hemolysis induced by sample handling.
IP‑injection timing
Sampling immediately before the IP-injection yielded sub-
stantially higher initial glucose levels than sampling imme-
diately (within seconds) after IP-injection (mean ± s.e., 
before: 12.9 ± 0.35; after: 10.9 ± 0.21; β = 1.98 ± 0.38 mM, 
F1,80 = 26.52, P < 0.001, Table  S1; data experiment 1, 
Table 1). Whether the IP-injection was loaded with 0 or 
20% glucose in interaction with sampling time (before or 
after injection) did not affect initial glucose levels (IP-load x 
sampling timing F1,78 = 0.38, P = 0.54), presumably because 
the interval between IP-injection and sampling was less than 
one minute.
The effect of sampling time relative to the IP-injection 
persisted over the subsequent time points, with individu-
als sampled immediately after the IP-injection having lower 
PI glucose levels than individuals sampled just before the 
IP-injection (Fig. 1; β =  − 2.42 ± 0.52 mM, F1,115.5 = 21.30, 
P < 0.001, Table S1; data experiment 2, Table 1). This 
effect did not change significantly over successive samples 
as indicated by the non-significant interaction between ini-
tial sampling timing and the sample number (F3,157.1 = 0.39, 
P = 0.76). Furthermore, there was no interaction between IP-
injection time and IP-injection load (i.e. 0 or 20% glucose) 
on blood glucose levels (F1,71.0 = 0.27, P = 0.61). Glucose 
levels increased over time in both 0 and 20% glucose IP-
injected birds (Fig. 1; all pair-wise comparisons between 
initial and > 10  min PI levels, P < 0.01), yet the incre-
ment was more pronounced in glucose IP-injected birds 



















|                                                |                                                |                          |
T0                         T10                        T20                         T40
Minutes after IP-injection
Pre-injection / 20% glucose
Pre-injection / 0% glucose
Post-injection / 20% glucose
Post-injection / 0% glucose
Fig. 1  Effect of timing of initial sampling and injection load on glu-
cose levels. Initial glucose sample (T0) was taken after 30 min fasting 
and immediately before (dashed lines) or after (solid lines) a glucose 
injection (i.e. pre-injection or post-injection sample). Intra-peritoneal 
injection was loaded with either 0% (open dots) or 20% glucose (solid 
dots). Note that to avoid overlapping s.e.’s markers were slightly dis-
placed along the X-axis. Data from experiment 2
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of experiments 1 and 2 (Table 1), IP-injection was performed 
after initial sampling in all subsequent tests.
Sampling frequency
The observation in experiment 2 that glucose levels 
increased with successive sampling, also when only vehicle 
was injected, was reason to test the effect of sampling fre-
quency on glucose levels directly in experiment 3 (Table 1). 
This revealed that birds sampled at T0 and T40 min PI 
only had lower glucose levels at T40 min PI compared to 
birds additionally sampled at intermediate time points T10 
and T20 min PI (Fig. 2; sample × handling F1,41.5 = 14.11, 
P < 0.001, Table S1). In this experiment, blood glucose lev-
els at T40 min PI were indistinguishable from initial glucose 
levels when no samples were taken at T10 and T20 min, 
even when birds were injected with 20% glucose (IP-glucose 
load × handling F1,40.2 = 1.18, P = 0.28, Table S1). Contrast-
ingly, blood glucose was maintained elevated above initial 
glucose levels at T40 min PI, when birds were resampled 
between the initial and final sample.
Glucose doses
Considering that successive handling had a stronger effect on 
glucose levels than the 20% glucose load of the IP-injection 
(Fig. 2), in experiment 4 we tested whether increasing IP-
injection load from 20 to 30% glucose would increase blood 
glucose levels further (Table 1). When comparing blood 
glucose levels over all time points (i.e. T0, T10, T20 and 
T40 min PI-samples) among birds IP-injected with 0, 20 or 
30% glucose, we found a significant interaction between the 
IP-injection load and the sample number (F6,128.6 = 19.85, 
P < 0.001, Table S1). Blood glucose levels of birds IP-
injected with 0 or 20% glucose differed significantly at T20 
min PI only (post-hoc test t67.4 = -3.40, P = 0.05; at T10 and 
T40 min: P > 0.66, Table S1). In contrast, blood glucose 
levels of birds IP-injected with 30% glucose differed from 
0 and 20% IP-injected birds at all PI time points (post-hoc 
tests: all P < 0.001; Fig. 3). Hence, IP-injection was loaded 
with 30% glucose in all subsequent trials.
Glucose tolerance test
In experiment 5, we performed the glucose tolerance test 
(GTT) following the conditions developed using results of 
experiments 1–4 (Table 1). PI glucose levels varied sig-
nificantly among time points (F3,67.0 = 40.52, P < 0.001) 
and were elevated above initial levels at all PI time 
points (Fig. 4a; T10 min: β = 9.98 ± 1.11 mM, T20 min: 
β = 11.21 ± 1.12 mM, T40 min: β = 7.01 ± 1.14 mM; all 
post-hoc tests P < 0.001). Glucose levels peaked on average 
at T20 min PI (mean ± S.E. mM, T0 min: 14.34 ± 0.53; T10 
min PI: 24.19 ± 1.23; T20 min PI: 25.53 ± 0.77), and had not 
yet reached initial level at T40 min PI (21.40 ± 0.98 mM). 
Interestingly, there was inter-individual variation in the 
time at which glucose levels peaked: 37.5% of the individu-
als peaked at T10 min PI, 50% peaked at T20 min PI, and 
in the remaining 12.5% glucose peaked T40 min PI. The 
magnitude of AUC in tests performed over 40 min varied 
depending on the timing of the peak (F2,84 = 3.31, P = 0.04), 
being higher when the peak was reached at 20 min PI. com-
pared to peaks at both T10 and T40 min PI. Moreover, the 
AUC increased with the magnitude of the glucose peak 

















|                                                                                                                            |
T0                                                                     T40
Minutes after IP-injection
Four samples / 20% glucose
Four samples / 0% glucose
Two samples / 20% glucose
Two samples / 0% glucose
A
Fig. 2  Effect of sampling frequency and injection load on glucose 
levels (mean ± s.e.). Birds were sampled either two (i.e. T0 and T40 
min PI; dashed lines) or four times (i.e. T0, T10, T20 and T40 min 
PI; solid lines); for clarity the results at T10 and T20 min PI are not 
shown. In all cases, first sample (T0) was taken after 30 min fasting. 
IP-injection was loaded with either 0% (open dots) or 20% glucose 
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Fig. 3  Effect of injection load on glucose levels (mean ± s.e.). Birds 
were IP-injected with 0% (open dots and solid line), 20% (closed dots 
and dashed line) or 30% glucose (closed dots and solid line). In all 
cases, first sample (T0) was taken after 30 min fasting. Note that to 
avoid overlapping s.e.’s markers were slightly displaced along the 
X-axis. Data from experiment 4, all individuals were blood sampled 
four times
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Because only two out of the 24 individuals tested 
(experiment 5) reached initial glucose levels at T40 min 
PI, we repeated the test using a different set of indi-
viduals, but with the fourth sample taken at T120 min 
PI instead of T40 min PI (experiment 6). Blood glu-
cose levels again differed among PI sampling points 
(F3,62.22 = 38.05, P < 0.001), and at T120 min PI blood 
glucose levels were still higher than initial levels (Fig. 4b, 
post-hoc test t62.2 = -2.67, P < 0.05). Only one out of 22 
individuals had reached their initial level at T120 min 
PI. Therefore, to reduce the timespan of the protocol, 
which is desirable for practical and welfare reasons, the 
last sample in our final protocol was taken at T40 min PI.
Repeatability
A different set of birds (i.e. not used in experiments 1–6, 
n = 28, 15 females and 13 males) was tested twice with a 
two-month interval to estimate the repeatability of AUC 
under the IP-GTT developed through experiments 1–6. 
Repeatability of each time point of the glucose curve 
ranged from 37 to 63% (T0 min = 54%, CI = 23–76%; T10 
min = 63%, CI = 35–81%; T20 min = 51%, CI = 18–74%; 
T40 min = 37%, CI = 1–65%). AUC repeatability was 50% 
(Fig. 5a; 95% C.I. 30–79%) calculated over all time points, 
while repeatability of the AUCpeak, including only sam-
pling points up to average peak levels (T0, T10 and T20 min 
PI), was comparable at 47% (Fig. 5b; 95% C.I. 13–71%). 
Similar to results obtained in experiment 5, in tests per-
formed to calculate repeatability estimates, we also found 
that AUC was higher when the peak was reached at T20 min 
PI (F2,43.0 = 12.43, P < 0.001), and when the magnitude of 
the glucose peak was more elevated (β = 26.47 ± 2.10 mM, 
F1,47.1 = 159.22, P < 0.001).
Discussion
Our primary interest was to quantify variation among indi-
viduals in the ability to regulate blood glucose levels, and to 
this end we adapted the IP-GTT for application in the zebra 
finch. We estimated the extent of individual variation by 
calculating the repeatability of the performance of individu-
als in response to the test. At repeatabilities of 50% (AUC; 
95% CI 30–79%), and 47% (AUCpeak; 95% CI 13–71%), the 
among-individual consistency in the response to a glucose 
challenge was substantial over months, and at a level com-
parable to the repeatability of 63–64% observed in horses 
(Bröjer et al. 2013; Pratt et al. 2005). We therefore conclude 
that glucose regulation can be considered an individual trait. 
The repeatability observed for the AUC was higher than the 
repeatability of 30% we reported previously for initial glu-
cose levels in the same population (Montoya et al. 2018), 
but close to that reported for corticosterone response to 
dexamethasone in the same study population (Jimeno et al. 
2018a), which can also be considered a test of the ability 
to recover stability after a challenge. Interestingly, in this 
study repeatability of initial glucose levels was higher at 
54% than what we previously reported (30%, Montoya et al. 
2018), and this could be associated with lower variability in 
the sampling conditions in the current study (i.e. all experi-
ments were performed in the same year, individuals were 
sampled/resampled during the same season, and exactly the 
same protocol was always used). Hence, the GTT provides 
information about the potential of the individual for dealing 
with challenges while maintaining the functionality of vital 
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Minutes after IP-injection
Fig. 4  Glucose levels shown by individual zebra finches during an IP-
glucose tolerance test. Initial blood sample (T0) was taken seconds 
before the IP-injection, and IP-injection was loaded with a solution 
of 30% glucose. Panel A shows data from experiment 5 and corre-
sponds to twenty-four individuals (9 females and 15 males) sampled 
for the last time at T40 min post injection. Panel B shows data from 
experiment 6 and comprises twenty-two individuals (10 females and 
12 males) sampled for the last time at T120 min PI. In both panels, 
the black thick line represents mean values
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environmental fluctuations), which has been proposed as a 
good estimate of individual’s condition (Hill 2011).
Glucose levels increase in response to various stressors, 
presumably through the action of glucocorticoids such as 
corticosterone (e.g. Jimeno et al. 2018b). Hence, it was 
not surprising that sampling by itself affected glucose lev-
els (Fig. 2), and this result suggests that a GTT response 
might also provide information about individual’s response 
to challenging conditions. The number of samples taken 
therefore needs to be considered carefully when developing 
a GTT, maintaining a balance between disturbance of the 
animal and resolution desired for the test. On the one hand, 
the effect of successive sampling on glucose levels, as well 
as welfare considerations, are reasons to minimize the fre-
quency of sampling. On the other hand, taking a larger num-
ber of samples allows a better description of the response to 
the glucose injection. This balance may be especially impor-
tant when performing this test in the wild, where it may be 
particularly informative on the capacity of the individual 
to deal with disturbances at different life stages, but at the 
same time, the number of samples taken may potentially 
affect the individual’s survival. Some alternatives to address 
this potential pitfall may be implementing the use of port-
able devices to measure glucose levels directly in the field, 
which requires small amounts of blood (see Tomasek et al. 
2019), and/or reduce the extension of the protocol aiming 
to obtain only AUCpeak which is highly repeatable (47%) 
and requires half of the time (20 min) of the full protocol 
(40 min) to be completed. The fact that blood glucose did not 
return to initial levels 40 min after the IP-injection, which is 
likely due to the effect of successive handling, limits the use 
of this protocol to evaluate glucose regulation.
In contrast to the increase in glucose levels due to succes-
sive sampling, the IP-injection itself resulted in an immedi-
ate decrease of blood glucose levels (within seconds), and 
this effect was independent of whether the injection was 
saline or glucose loaded. Surprisingly, the effect of taking 
the initial sample before or after the IP-injection persisted 
throughout the GTT (Fig. 1). In captive starlings (Sturnus 
vulgaris), glucose levels increased after a subcutaneous 
saline injection (Remage-Healey and Romero 2001). How-
ever, that increase was only evident 40 min after the injec-
tion, which is consistent with the fact that stress-induced 
hyperglycemia is evident only 15–20 min after inducing an 
acute stress response (Remage-Healey and Romero 2000). 
We hypothesize that our finding of an immediate depletion 
of the circulating glucose after the IP-injection is due to 
the immediate skeletomuscular activation in response to the 
handling required for performing the IP-injection, but this 
explanation needs to be verified (e.g. by IP-injecting labeled 
glucose). Alternatively, the IP-injected liquid, which was 
colder than body’s temperature, may have triggered a hypo-
glycemic response, as observed in birds acutely exposed 
to cold conditions (Thomas and George 1975; Parker and 
George 1976), but given the small volume of the injection 
(0.1 ml, less than 1% of body mass) this seems unlikely.
Glucose peaked at 25.53 and 20.04 mM on average 
(experiments 5 and 6 respectively). This large difference 
in peak values between experiments 5 and 6 suggests that 
there may be a seasonal effect on the magnitude of the 
























































Fig. 5  Individual repeatability of the glucose regulation response in 
a GTT. Panel A, individual repeatability of the area under the curve 
of glucose (AUC × 40 min; repeatability: 50%, 95% CI 30–79%) and 
panel B, individual repeatability of the area until reaching glucose 
peak (AUCpeak, up to and including T20 min post-injection; repeat-
ability: 47%, 95% CI 13–71%). AUC and AUCpeak were measured 
in an intra-peritoneal glucose tolerance test. Twenty-eight individuals 
(15 females and 13 males) were tested with an interval of two months 
between the first and the second measurement
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reported influence of ambient temperature on initial glu-
cose levels in this species (Montoya et al. 2018). Indeed, 
experiments 5 and 6 only differed in the month in which 
they were performed, with some overlapping weeks. 
Remarkably, despite the fact that the performance in the 
IP-GTT can be affected by seasonal variation, the within-
individual repeatability calculated over two months was 
moderate, which supports the idea that glucose regulation 
is an individual trait.
In the few other avian species in which a GTT was 
applied (two captive raptors’ species and one free living 
sea bird), glucose peak after a glucose load of 0.18–5 gr/
kg of glucose was reported to increase relative to initial 
glucose levels, reaching 6–30 mM above, and to reach the 
highest value between 5 and 90 min after glucose adminis-
tration (Chieri et al. 1972; Minick 1978; Myers and Klas-
ing 1999). This wide range of variation illustrates the need 
to establish and validate species-specific GTT protocols, 
such as the one we present here.
Results obtained here show that an individuals’ capacity 
to regulate glucose levels after a glucose administration 
is repeatable, hence it is an individual trait. This finding 
raises the question of what causes such individual varia-
tion, which will be of particular interest when this capacity 
is indeed a measure of ‘condition’, but this remains to be 
established. Measuring capacity to regulate glucose levels 
using an IP-GTT differs from estimating initial glucose, 
in that initial glucose levels provide only a snapshot at a 
single time-point, whereas the IP-GTT measures the indi-
vidual’s dynamic capacity to deal with challenges, which 
can potentially be considered an estimate of condition 
(Hill 2011). However, there is still very little information 
about the links between initial glucose levels, performance 
in a GTT and advanced glycation end products (AGEs). It 
remains to be established whether individual variation in 
the capacity to reduce experimentally increased glucose 
levels, and return to initial levels, reflects a general capac-
ity to deal with physiological challenges, or whether it is 
specific to the regulation of glucose.
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